DECAPRYN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Decapryn, and what generic alternatives are available?
Decapryn is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in DECAPRYN is doxylamine succinate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxylamine succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Decapryn
A generic version of DECAPRYN was approved as doxylamine succinate by PERRIGO on September 18th, 1996.
Summary for DECAPRYN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 95 |
Patent Applications: | 1,477 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DECAPRYN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DECAPRYN
US Patents and Regulatory Information for DECAPRYN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | DECAPRYN | doxylamine succinate | TABLET;ORAL | 006412-015 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | DECAPRYN | doxylamine succinate | TABLET;ORAL | 006412-014 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |